Ehrnsperger; Eric C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ehrnsperger; Eric C..The latest application filed is for "oral formulations and lipophilic salts of methylnaltrexone".

Company Profile

7.13.15

Ehrnsperger; Eric C. - New City NY
Ehrnsperger; Eric C. - Chestnut Ridge NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20200121673 - Shah; Syed M. ; et al.	2020-04-23
Oral formulations and lipophilic salts of methylnaltrexone Grant 10,507,206 - Shah , et al. Dec	2019-12-17
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20190314365 - Shah; Syed M. ; et al.	2019-10-17
Oral formulations and lipophilic salts of methylnaltrexone Grant 10,376,505 - Shah , et al. A	2019-08-13
Oral formulations and lipophilic salts of methylnaltrexone Grant 10,307,417 - Shah , et al.	2019-06-04
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20190117646 - Shah; Syed M. ; et al.	2019-04-25
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20190117645 - Shah; Syed M. ; et al.	2019-04-25
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20160206612 - Shah; Syed M. ; et al.	2016-07-21
Oral formulations and lipophilic salts of methylnaltrexone Grant 9,314,461 - Shah , et al. April 19, 2	2016-04-19
Oral formulations and lipophilic salts of methylnal trexone Grant 8,956,651 - Shah , et al. February 17, 2	2015-02-17
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20140249171 - Shah; Syed M. ; et al.	2014-09-04
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20130330407 - SHAH; Syed M. ; et al.	2013-12-12
Oral formulations and lipophilic salts of methylnaltrexone Grant 8,524,276 - Shah , et al. September 3, 2	2013-09-03
Oral Formulations And Lipophilic Salts Of Methylnaltrexone App 20120070495 - SHAH; Syed M. ; et al.	2012-03-22
Bazedoxifene acetate formulations Grant 7,771,744 - Shah , et al. August 10, 2	2010-08-10
Sustained-release formulation and uses thereof Grant 7,709,024 - Ali , et al. May 4, 2	2010-05-04
Serotonin and norepinephrine reuptake inhibitors and uses thereof Grant 7,687,520 - Shah , et al. March 30, 2	2010-03-30
Salicylate and gentisate salts of a piperazine compound Grant 7,615,551 - Deshmukh , et al. November 10, 2	2009-11-10
Glucuronate salt of a piperazine compound Grant 7,595,310 - Deshmukh , et al. September 29, 2	2009-09-29
Serotonin and norepinephrine reuptake inhibitor and uses thereof Grant 7,595,340 - Shah , et al. September 29, 2	2009-09-29
Glucuronate salt of a piperazine compound App 20070254876 - Deshmukh; Subodh S. ; et al.	2007-11-01
Sustained-release formulation and uses thereof App 20070059366 - Ali; Kadum ; et al.	2007-03-15
Salicylate and gentisate salts of a piperazine compound App 20070060580 - Deshmukh; Subodh S. ; et al.	2007-03-15
Bazedoxifene acetate formulations App 20070048374 - Shah; Syed M. ; et al.	2007-03-01
Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof App 20070015828 - Shah; Syed M. ; et al.	2007-01-18
Serotonin and norepinephrine reuptake inhibitor and uses thereof App 20070015824 - Shah; Syed M. ; et al.	2007-01-18
Serotonin and norepinephrine reuptake inhibitors and uses thereof App 20070015791 - Shah; Syed M. ; et al.	2007-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.